Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥ 65 years old): A systematic review and meta‐analysis
Direct‐acting agents (DAAs) have launched a new era of hepatitis C virus (HCV) treatment.
As aged individuals comprise a large percentage of HCV‐infected patients, the effectiveness …
As aged individuals comprise a large percentage of HCV‐infected patients, the effectiveness …
Impact of treating chronic hepatitis C with direct acting antivirals on health-related quality of life: a real-life Egyptian experience
M Elbadry, M Badawi, N Youssef, M Duracinsky… - Egyptian Liver …, 2024 - Springer
Background Chronic hepatitis C virus (HCV) infection negatively impacts health-related
quality of life (HRQL). We aimed to assess patient-reported outcomes (PROs) to evaluate the …
quality of life (HRQL). We aimed to assess patient-reported outcomes (PROs) to evaluate the …
Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center
M El Kassas, M Eltabbakh, M Elbadry… - Current Medical …, 2022 - Taylor & Francis
Efforts toward eradicating the Hepatitis C virus (HCV) have advanced rapidly, due to the
development of direct-acting antivirals (DAAs), especially with the appearance of pan …
development of direct-acting antivirals (DAAs), especially with the appearance of pan …
Morbidity and mortality during hepatitis C treatment using sofosbuvir and daclatasvir with or without ribavirin, in a cohort of Egyptian patients
HM Elsadek, ES Abdelbaser, MH Emara… - European Journal of …, 2020 - journals.lww.com
Background Though direct-acting antiviral agents (DAAs) therapy is associated with a high
cure rate of hepatitis C virus infection, a potential risk of serious adverse events (SAEs) …
cure rate of hepatitis C virus infection, a potential risk of serious adverse events (SAEs) …